Purification and characterization of human adrenomedullin binding protein-1

Molecular Medicine

Volumn 14, Issue 7-8, 2008, Pages 443-450

  Qiang, Xiaoling ^a   Wu, Rongqian ^a   Ji, Youxin ^a   Zhou, Mian ^a   Wang, Ping ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN BINDING PROTEIN 1; BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOACCUMULATION; BIOLOGICAL ACTIVITY; BLEEDING; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEMORRHAGIC SHOCK; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; POWDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN STABILITY; RAT; SERUM; STORAGE TEMPERATURE; TISSUE INJURY;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; COMPLEMENT FACTOR H; DRUG EVALUATION, PRECLINICAL; HEMORRHAGE; HUMANS; INTERLEUKIN-6; ISCHEMIA; LIPOPOLYSACCHARIDES; LIVER DISEASES; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; SERUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48149097392     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2008-00015.Qiang     Document Type: Article

References (26)

1. Sugo S, et al. (1994) Endothelial cells actively synthesize and secrete adrenomedullin. Biochem. Biophys. Res. Commun. 201:1160-6.
2. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T (1994) Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 338:6-10.
3. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:553-60.
4. Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG (2000) Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J. Clin. Endocrinol. Metab. 85:1016-20.
5. Rademaker MT, et al. (1997) Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 96:1983-90.
6. Elsasser TH, Kahl S, Martinez A, Montuenga LM, Pio R, Cuttitta F (1999) Adrenomedullin binding protein in the plasma of multiple species: characterization by radioligand blotting. Endocrinology 140:4908-11.
7. Pio R, et al. (2001) Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J. Biol. Chem. 276:12292-300.
8. Yang S, Zhou M, Chaudry IH, Wang P (2002) Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann. Surg. 236:625-33.
9. Wu R, Cui X, Dong W, Zhou M, Simms HH, Wang P (2005) Mechanisms responsible for vascular hyporesponsiveness to adrenomedullin after hemorrhage: the central role of adrenomedullin binding protein-1. Ann. Surg. 242:115-23.
10. Wu R, Dong W, Zhou M, Cui X, Simms HH, Wang P (2005) A novel approach to maintaining cardiovascular stability after hemorrhagic shock: beneficial effects of adrenomedullin and its binding protein. Surgery 137:200-8.
11. Zhou M, Ba ZF, Chaudry IH, Wang P (2002) Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283:R553-60.
12. Zhou M, Simms HH, Wang P (2004) Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann. Surg. 240:321-30.
13. Sim RB, DiScipio RG (1982) Purification and structural studies on the complement-system control protein beta 1H (factor H). Biochem. J. 205:285-93.
14. Wu R, Zhou M, Wang P (2003) Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul. Pept. 112:19-26.
15. Dwivedi AJ, et al. (2007) Adrenomedullin and adrenomedullin binding protein-1 prevent acute lung injury after gut ischemia-reperfusion. J. Am. Coll. Surg. 205:284-93.
16. Deitch EA, Dayal SD (2006) Intensive care unit management of the trauma patient. Crit. Care Med. 34:2294-301.
17. Moore FA, McKinley BA, Moore EE (2004) The next generation in shock resuscitation. Lancet 363:1988-96.
18. Scalea TM, Maltz S, Yelon J, Trooskin SZ, Duncan AO, Sclafani SJ (1994) Resuscitation of multiple trauma and head injury: role of crystalloid fluids and inotropes. Crit. Care Med. 22:1610-5.
19. Abou-Khalil B, Scalea TM, Trooskin SZ, Henry SM, Hitchcock R (1994) Hemodynamic responses to shock in young trauma patients: need for invasive monitoring. Crit. Care Med. 22:633-9.
20. Cotton BA, Guy JS, Morris JA Jr. Abumrad NN (2006) The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 26:115-21.
21. Moore FA, et al. (2006) Inflammation and the host response to injury, a large-scale collaborative project: patient-oriented research core - standard operating procedures for clinical care. III. Guidelines for shock resuscitation. J. Trauma 61:82-9.
22. Clifford CC (2004) Treating traumatic bleeding in a combat setting. Mil. Med. 169:8-10, 4.
23. Cui X, et al. (2005) Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. Crit. Care Med. 33:391-8.
24. Wu R, Wang P (2006) Preclinical studies with adrenomedullin and its binding protein as cardiovascular protective agents for hemorrhagic shock. Cardiovasc. Drug Rev. 24:204-13.
25. Pelletier JP, Transue S, Snyder EL (2006) Pathogen inactivation techniques. Best Pract. Res. Clin. Haematol. 19:205-42.
26. Gonzalez-Rey E, Chorny A, Varela N, Robledo G, Delgado M (2006) Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. Am. J. Pathol. 168:1921-30.